URGENT UPDATE: Global biotech leaders are set to converge in San Francisco on January 14, 2026, for the 5th Annual Biotech Global Forum, hosted by GenScript Biotech Corporation. This pivotal event coincides with the renowned J.P. Morgan Healthcare Conference, emphasizing its significance in the biotech ecosystem.
The Forum will feature both in-person and virtual attendance options, allowing scientists, innovators, and investors to engage in critical discussions on the future of biotechnology. Under the theme “Scripting Possibilities,” attendees will explore groundbreaking advancements in cell and gene therapies and next-generation biotherapeutics.
“The Global Forum has become a central gathering point for leaders driving progress across the biotech ecosystem,” said Sherry Shao, CEO of GenScript Biotech Corp. She added that the Forum aims to empower researchers and companies through integrated technologies, accelerating the delivery of innovations to patients worldwide.
This year’s forum will showcase two keynote speakers who are reshaping the landscape of biotechnology: David Baker, PhD, a Nobel Laureate in Chemistry and Director of the Institute for Protein Design, and Eric Horvitz, PhD, MD, Chief Scientific Officer at Microsoft. Their insights into computational protein design and artificial intelligence will highlight the convergence of biology and technology.
Key highlights of the Forum include:
– **Keynote & Fireside Conversation:** In-depth discussions on the future of therapeutic innovation.
– **Insight-Driven Panel Sessions:** Exploring the next frontier in AI-enabled drug discovery and the evolution of biotech.
– **Technology Showcase:** Featuring GenScript’s innovative Dark Lab and GenGenius+ automation platform, demonstrating AI’s impact on laboratory workflows.
– **Advanced Therapy Spotlight:** Perspectives on translating CGT innovation into scalable solutions backed by GenScript’s expertise.
– **High-Impact Networking:** Opportunities for collaboration among scientists, biotech leaders, and investors.
“Biotechnology is at an inflection point – where speed, precision, and collaboration are no longer optional,” stated Ray Chen, PhD, President of GenScript Life Science Group. He emphasized that the Forum will explore how these forces can align to expedite scientific discoveries and deliver therapies to patients more rapidly.
Registration for the GenScript Biotech Global Forum is now open. For more information and to register, visit GenScript’s official website.
This is a critical moment for the biotech industry as it pushes the boundaries of scientific innovation, ensuring that groundbreaking treatments become available to patients sooner than ever. Share this news to keep your network informed about this transformative event!
